Wells Fargo & Company Rocket Pharmaceuticals, Inc. Transaction History

Wells Fargo & Company

$410 Billion
Q1 2024

A detailed history of Wells Fargo & Company transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 22,840 shares of RCKT stock, worth $563,691. This represents 0.0% of its overall portfolio holdings.

Number of Shares

22,840

Previous 25,706 11.15%

Holding current value

$563,691

Previous $770,000 20.13%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$26.16 - $30.74 $74,974 - $88,100	-2,866 Reduced 11.15%	22,840 $615,000
Q4 2023 Feb 09, 2024	SELL	$16.78 - $31.94 $569,580 - $1.08 Million	-33,944 Reduced 56.91%	25,706 $770,000
Q3 2023 Nov 13, 2023	SELL	$15.07 - $24.05 $123,227 - $196,656	-8,177 Reduced 12.06%	59,650 $1.22 Million
Q2 2023 Aug 15, 2023	BUY	$16.59 - $23.6 $57,285 - $81,490	3,453 Added 5.36%	67,827 $1.35 Million
Q1 2023 May 12, 2023	BUY	$15.79 - $22.6 $974,716 - $1.4 Million	61,730 Added 2334.72%	64,374 $1.1 Million

Q4 2022 Feb 13, 2023	BUY	$15.5 - $22.76 $15,980 - $23,465	1,031 Added 63.92%	2,644 $51,000
Q3 2022 Nov 14, 2022	SELL	$12.37 - $18.41 $85,019 - $126,531	-6,873 Reduced 80.99%	1,613 $26,000
Q2 2022 Aug 12, 2022	SELL	$7.96 - $16.64 $26,490 - $55,377	-3,328 Reduced 28.17%	8,486 $117,000
Q1 2022 May 16, 2022	SELL	$13.16 - $23.68 $161,578 - $290,743	-12,278 Reduced 50.96%	11,814 $186,000
Q4 2021 Feb 14, 2022	BUY	$21.52 - $36.02 $75,104 - $125,709	3,490 Added 16.94%	24,092 $526,000
Q3 2021 Nov 15, 2021	SELL	$27.42 - $48.97 $158,652 - $283,340	-5,786 Reduced 21.93%	20,602 $616,000
Q2 2021 Aug 16, 2021	BUY	$39.41 - $47.25 $22,069 - $26,460	560 Added 2.17%	26,388 $1.17 Million
Q1 2021 May 13, 2021	SELL	$43.34 - $65.91 $326,090 - $495,906	-7,524 Reduced 22.56%	25,828 $1.15 Million
Q4 2020 Feb 09, 2021	BUY	$23.3 - $59.57 $294,442 - $752,786	12,637 Added 61.0%	33,352 $1.83 Million
Q3 2020 Nov 05, 2020	SELL	$20.5 - $28.59 $250,448 - $349,284	-12,217 Reduced 37.1%	20,715 $474,000
Q2 2020 Aug 13, 2020	BUY	$13.32 - $22.61 $95,011 - $161,277	7,133 Added 27.65%	32,932 $690,000
Q1 2020 May 14, 2020	BUY	$9.71 - $25.11 $250,508 - $647,812	25,799 New	25,799 $360,000

Others Institutions Holding RCKT

# of Institutions

206

Shares Held

92.9M

Call Options Held

341K

Put Options Held

107K

View Full List

About ROCKET PHARMACEUTICALS, INC.

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $1.87B
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

More about RCKT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Rocket Pharmaceuticals, Inc. Transaction History